SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 192.97-1.6%Jan 16 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Night Trader who wrote (12927)1/1/1998 7:52:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
martin, The current Zack's report is exactly the same as the last. LGND still has 3 STRONG BUYS (Bear Stearns, Roberston Stephens, and Lehman Brothers) and 1 BUY (Hambrecht & Quist). In the past they had a STRONG BUY from Raymond James, who at the present time has dropped coverage.

When you initially indicated that Raymond James had changed LGND's rating from a STRONG BUY to a HOLD, there were questions raised and they seem to be legitimate (I have yet to see a Zack's listing showing the Raymond James HOLD rec). The current rec list is the same as the last (and there is no HOLD rec).

As far as the new Bear Stearns' estimate is concerned, I am fairly certain that it represents the first prediction of a LGND profit for this year. Prior to LGND's statements on profitability in 1999, all other analysts had projected a significant loss for 1999, well in excess of $1.00 (as also reported by Jesse Eisinger).

No one commented on a change in this week's ratings for LGND because THERE WAS NO CHANGE. Last week it was 3 STRONG BUYS and 1 BUY and its the same this week. LGND had 4 STRONG BUYS and 1 BUY for many months. The only recent change was the one you reported several weeks ago when Raymond James stopped coverage.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext